Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus
- PMID: 23613635
- PMCID: PMC3631993
- DOI: 10.3748/wjg.v19.i15.2395
Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus
Abstract
Aim: To determine the association of diabetes mellitus (DM) and international normalized ratio (INR) level in hepatocellular carcinoma (HCC) patients.
Methods: Our present study included 375 HCC patients who were treated at the China-Japan Friendship Hospital, Ministry of Health (Beijing, China), in the period from January 2003 to April 2012, and with a hospital discharge diagnosis of HCC. The demographic, clinical, laboratory, metabolic and instrumental features were analyzed. χ² test, Student's t test and Mann-Whitney U test were used to compare the differences between HCC patients with and without DM. Unconditional multivariable logistic regression analysis was used to determine the association of DM and INR level in HCC patients. A sub-group analysis was performed to assess the effect of liver cirrhosis or hepatitis B virus (HBV) infection on the results. The Pearson correlation test was used to determine the relationship between INR level and fasting glucose. In addition, association between diabetes duration, and diabetes treatment and INR level was determined considering the potentially different effects.
Results: Of the total, 63 (16.8%) patients were diabetic (diabetic group) and 312 (83.2%) patients were diagnosed without diabetes (non-diabetic group). Their mean age was 56.4 ± 11.0 years and 312 (83.2%) patients were male. Compared with patients without DM, the HCC patients with diabetes were older (59.5 ± 10.3 vs 55.8 ± 11.1, P = 0.015), had a lower incidence of HBV infection (79.4% vs 89.1%, P = 0.033), had increased levels of systolic blood pressure (SBP) (133 ± 17 vs 129 ± 16 mmHg, P = 0.048) and INR (1.31 ± 0.44 vs 1.18 ± 0.21, P = 0.001), had lower values of hemoglobin (124.4 ± 23.9 vs 134.2 ± 23.4, P = 0.003) and had a platelet count (median/interquartile-range: 113/64-157 vs 139/89-192, P = 0.020). There was no statistically significant difference in the percentages of males, overweight or obesity, drinking, smoking, cirrhosis and Child classification. After controlling for the confounding effects of age, systolic blood pressure, hemoglobin, platelet count and HBV infection by logistic analyses, INR was shown as an independent variable [odds ratio (OR) = 3.650; 95%CI: 1.372-9.714, P = 0.010]. Considering the effect of liver cirrhosis on results, a sub-group analysis was performed and the study population was restricted to those patients with cirrhosis. Univariate analysis showed that diabetic patients had a higher INR than non-diabetic patients (1.43 ± 0.51 vs 1.25 ± 0.23, P = 0.041). After controlling for confounding effect of age, SBP, hemoglobin, platelet count and HBV infection by logistic analyses, INR level remained as the sole independent variable (OR = 5.161; 95%CI: 1.618-16.455, P = 0.006). No significant difference in the relationship between INR level and fasting glucose was shown by Pearson test (r = 0.070, P = 0.184). Among the 63 diabetic patients, 35 (55.6%) patients had been diagnosed with DM for more than 5 years, 23 (36.5%) received oral anti-diabetic regimens, 11 (17.5%) received insulin, and 30 (47.6%) reported relying on diet alone to control serum glucose levels. No significant differences were found for the association between DM duration/treatment and INR level, except for the age at diabetes diagnosis.
Conclusion: The INR level was increased in HCC patients with DM and these patients should be monitored for the coagulation function in clinical practice.
Keywords: Chinese patients; Coagulation function; Diabetes mellitus; Hepatocellular carcinoma; International normalized ratio.
Similar articles
-
Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection.Hepatobiliary Pancreat Dis Int. 2013 Aug;12(4):385-93. doi: 10.1016/s1499-3872(13)60060-0. Hepatobiliary Pancreat Dis Int. 2013. PMID: 23924496
-
Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis.World J Gastroenterol. 2010 Sep 21;16(35):4467-75. doi: 10.3748/wjg.v16.i35.4467. World J Gastroenterol. 2010. PMID: 20845516 Free PMC article.
-
Diabetes Mellitus is a Risk Factor for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection in China.Med Sci Monit. 2018 Sep 24;24:6729-6734. doi: 10.12659/MSM.911702. Med Sci Monit. 2018. PMID: 30245503 Free PMC article.
-
[Occult hepatitis B virus infection and hepatocellular carcinoma].Korean J Gastroenterol. 2013 Sep;62(3):160-4. doi: 10.4166/kjg.2013.62.3.160. Korean J Gastroenterol. 2013. PMID: 24077626 Review. Korean.
-
The prognosis of patients with co-morbid diabetes and hepatitis B and strategies for improving outcome.Am J Med Sci. 2025 May;369(5):638-641. doi: 10.1016/j.amjms.2024.12.011. Epub 2024 Dec 20. Am J Med Sci. 2025. PMID: 39710356 Review.
Cited by
-
Metformin Improves Biochemical and Pathophysiological Changes in Hepatocellular Carcinoma with Pre-Existed Diabetes Mellitus Rats.Pathogens. 2021 Jan 11;10(1):59. doi: 10.3390/pathogens10010059. Pathogens. 2021. PMID: 33440701 Free PMC article.
-
Increased Level of Systolic Blood Pressure in Hepatocellular Carcinoma Patients with Diabetes Mellitus.Diabetes Metab Syndr Obes. 2020 Jun 15;13:1979-1988. doi: 10.2147/DMSO.S251943. eCollection 2020. Diabetes Metab Syndr Obes. 2020. PMID: 32606857 Free PMC article.
-
Molecular pathological epidemiology in diabetes mellitus and risk of hepatocellular carcinoma.World J Hepatol. 2016 Sep 28;8(27):1119-1127. doi: 10.4254/wjh.v8.i27.1119. World J Hepatol. 2016. PMID: 27721917 Free PMC article. Review.
-
Diabetes Mellitus and Prediabetes in Patients with Hepatocellular Carcinoma in a Tertiary Philippine Hospital.J ASEAN Fed Endocr Soc. 2017;32(1):32-37. doi: 10.15605/jafes.032.01.06. Epub 2017 May 4. J ASEAN Fed Endocr Soc. 2017. PMID: 33442082 Free PMC article.
-
The prognostic role of diabetes mellitus type 2 in the setting of hepatocellular carcinoma: a systematic review and meta-analysis.Croat Med J. 2022 Apr 30;63(2):176-186. doi: 10.3325/cmj.2022.63.176. Croat Med J. 2022. PMID: 35505651 Free PMC article.
References
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5–S16. - PubMed
-
- Zhang H, Gao C, Fang L, Zhao HC, Yao SK. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis. Scand J Gastroenterol. 2013;48:78–87. - PubMed
-
- Gao C, Yao SK. Diabetes mellitus: a “true” independent risk factor for hepatocellular carcinoma? Hepatobiliary Pancreat Dis Int. 2009;8:465–473. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous